a numerical trendp = 0.396
Although not statistically significant, the normal group showed a numerical trend toward benefit from adjuvant chemotherapy (HR 0.70, 95% CI 0.30–1.61, p = 0.396), whereas this trend was not observed in patients with presarcopenia (HR 1.70, 95% CI 0.40–7.26, p = 0.475).